BCC Research
View Existing Reports | Report Subscriptions | Upcoming Reports | Press Room
 

Pharmaceuticals

Orthopedic Drugs, Implants and Devices  

Report Code: PHM040A, Published: October 2004


 
 

REPORT HIGHLIGHTS

  • The total orthopaedic drug, implant and device market is expected to reach $44 billion by end of 2004. Rising at an average annual growth rate (AAGR) of 11%, the market is expected to reach $74.1 billion by 2009.
  • Orthopedic drugs take about three quarters of the market and it is expected to rise at an AAGR of 10.5% reaching $56.2 billion by 2009.
  • In this category, skeletal muscle relaxants are increasing at a very low AAGR, i.e., 4%, while bone stabilizers and disease modifying agents are rising rapidly at AAGRs of 13.8% and 13.2%, respectively.
  • Sales in 2003 for implants and devices were $8.7 billion and are expected to rise at an AAGR of 12.5% and reach $17.9 billion by 2009.

Report Code: PHM040A, Published: October 2004, Analyst: Shalini Shahani

 
 

   Bookmark and Share


   

 Visit the Table of Contents  to purchase the report or to  download the introduction  chapter for free.



All transactions on our web site are conducted on a Secure SSL Server.
Copyright 2010 © All rights reserved.   About Us | Contact Us | Careers | Privacy Policy  |  Site Map |  XML Map